In this presentation and discussion, CAPT Ted Hall and CDR Teresa Grund discuss the changes in data waiver (x-waiver) requirements, other legislative updates, and the crucial and active role pharmacists… […]
Keyword: SUD
Substance Use Data Among American Indian/Alaska Natives | February 21, 2023
In this presentation, Michael Mudgett, reviews the latest substance use epidemiology data among American Indian/Alaska Natives at the IHS regional and national level. […]
Read More… from Substance Use Data Among American Indian/Alaska Natives | February 21, 2023
Harm Reduction Outreach Methods | February 7, 2023
In this presentation O’Nesha Cochran-Dumas shares her experience in harm reduction work in varied settings and how to address needs and outreach in different locations. She talks about the core… […]
Read More… from Harm Reduction Outreach Methods | February 7, 2023
Managing Opioid Use Disorder in the Era of Fentanyl | February 2, 2023
In this presentation Dr. Julie Byler, DO explains the unique characteristics of fentanyl and how they contribute to challenges in OUD management, discusses novel buprenorphine induction techniques and the evidence… […]
Read More… from Managing Opioid Use Disorder in the Era of Fentanyl | February 2, 2023
Stimulant Induced Psychosis | January 17, 2023
In this presentation, CDR Venecia Clark reviews the diagnosis and clinical manifestation of Stimulant Induced Psychosis (SIP). Moreover, differential diagnoses in the treatment of SIP and appropriate treatment options will… […]
Read More… from Stimulant Induced Psychosis | January 17, 2023
The Indigenous HIV/AIDS Syndemic Strategy | January 24, 2023
To support the development of comprehensive solutions to end the HIV epidemic in Indian Country, the Northwest Portland Area Indian Health Board, alongside the Indian Health Service National HIV Program,… […]
Read More… from The Indigenous HIV/AIDS Syndemic Strategy | January 24, 2023
Induction with Buprenorphine for Pregnant & Parenting Patients with SUD | December 1st 2022
In this presentation, Dr. Mishka Terplan, discusses professional recommendations on buprenorphine (and methadone) as a safe and effective treatment option during pregnancy and for parenting individuals. He presents maternal benefits of… […]
Evaluation of Infectious Diseases in People with SUD | November 9, 2022
In this presentation Jorge Mera, MD, discusses evaluation of infectious diseases for people with substance use disorders. He discusses a clinical case, the syndemic of HIV, HCV, STIs and SUDs, the… […]
Read More… from Evaluation of Infectious Diseases in People with SUD | November 9, 2022
Preventing, Monitoring and Treating Infectious Diseases in the MAT Clinic | November 3 2022
In this presentation Whitney Essex, APRN-CNP shares on prevention, monitoring, and treating infectious diseases in the setting of pharmacotherapy for substance use disorders. She discusses infectious diseases associated with substance use… […]
Language of Addiction | October 19, 2022
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the… […]











































